Introduction: Although depression is often associated with poor glycemic control in patients with type 2 diabetes mellitus (T2DM), this observation has been inconsistent. This complications at baseline. Patients with a history of diagnosed depression or high diabetes-related distress had higher HbA1c than patients without.
The latter two measures were assessed at baseline and 5 time points throughout the study. Glycemic control was measured by glycated hemoglobin (HbA1c) at these same time points. Analyses employed t tests to assess the unadjusted baseline difference in HbA1c between patients with and without the respective depression parameter. The potential effect of demographic and clinical confounding variables was controlled through a linear model structure. Patient HbA1c levels were analyzed by presence/absence of a history of diagnosed depression, depressed mood, and diabetesrelated distress.
Results: Patients with higher depression parameters or distress at baseline had significantly higher rates of microvascular Electronic supplementary material The online version of this article (doi:10.1007/s13300-015-0118-y) contains supplementary material, which is available to authorized users.
INTRODUCTION
Depression affects approximately 20-25% of patients with diabetes [1] , with rates of major depressive disorder estimated at 12% and depressive symptoms at 15-35% [2] . The presence of depressive symptoms is associated with a poorer quality of life in patients with diabetes and has been shown to be associated with poorer glycemic control and diabetes complications [3] [4] [5] [6] [7] . Similar associations have been reported with subthreshold depression [7] .
The relationship between glycemic control and depression is likely bidirectional, but the causal pathways remain incompletely understood [8] . Although poorer self-care among diabetes patients (e.g., adherence to lifestyle recommendations and glucose monitoring) is regarded as a potential contributor to poor glycemic control over time, it cannot fully account for poor control, as depression may also impact stress pathways which in turn can affect glycated hemoglobin (HbA1c) levels [9, 10] . However, interventions aimed at reducing depression among patients with diabetes have not led to the reduction in HbA1c or improvements in self-care behaviors, and conversely, an intervention trial to improve diabetes self-care and glycemic control in elderly patients with diabetes did not lead to reduction in depression [11, 12] .
Although major depressive disorder and depressive symptoms have generally been considered to be associated with poor glycemic control in type 2 diabetes mellitus (T2DM), the available data from cross-sectional studies on this association are inconsistent and methodological approaches vary across studies [2, 9, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . Diabetes-related distress refers to the emotional burden that may be an aspect of managing a chronic illness, and can be found in both those with diabetes and their caregivers [26] . It is different from the clinical experience of depression [27] [28] [29] [30] , as it may manifest more in emotional reactions to diabetes and its treatment. High levels of distress have been significantly linked to elevated HbA1c [29, 31] .
Importantly, a prospective, observational, noninterventional study by Fisher and colleagues [8] [32, 33] , which contributes to long delays in the start of insulin therapy [34] [35] [36] [37] .
Psychological resistance to insulin is a multifaceted, encompassing fear of insulin and the potential side effects of hypoglycemia and weight gain, complexity of insulin treatment and regimens, need to self-monitor blood glucose to adapt doses, and emotional factors such as anxiety or depression symptoms [32, 33, [38] [39] [40] [41] .
Inconsistencies in our understanding regarding the link between glycemic control and depression may be due, in part, to the reliance on diverse measures of depression. These include a previous depression diagnosis (either from claims data, medical records, or self-reported), results from depression diagnostic screening tools (e.g., [27, 42] . A report from the National Institute of Diabetes, Digestive and Kidney Diseases on diabetes and depression points out that the definition of depression varies across studies due to the variability of measurement and use of undefined terminology [43] .
To help clarify the link between glycemic control and depression, this study investigated the association between three types of depression/diabetes distress parameters (depression diagnosis, depressed mood, and diabetes-related distress) over 24 months in patients with T2DM initiating insulin in a large, observational, non-interventional trial.
METHODS
Data from the TREAT study [44] (3) the relationships between the three studied proxy measures of depression/distress. This analysis evaluated depression in three ways: 1. History of depression diagnosis-a history of depression diagnosis was recorded by the investigator at baseline (''Has the patient ever been diagnosed with any significant diagnosis other than diabetes:
depression?''). 2. Depressed mood-severity of depressed mood was assessed per patient self-report on the EQ-5D depression/anxiety item (''I am not anxious or depressed.''; ''I am moderately anxious or depressed.''; ''I am extremely anxious or depressed.'') scored as 0 (not), 1 (moderately), or 2 (extremely).
Presence of depressed mood was defined as a score of 1 or 2.
Diabetes distress-diabetes-related distress
was assessed by the Psychological Distress domain of the DHP-18, which included six items that asked the patients about the impact of diabetes on their mood (e.g., getting depressed, losing temper, or becoming upset, argumentative or moody), with each item being scored as 0 (never), 1 (sometimes), 2 (often), or 3 (very often Group comparisons on HbA1c were performed with two-sample t tests at each time point (unadjusted analysis). An adjusted analysis was also performed to adjust for the effect of potential confounding variables and estimate the association that would be seen should the comparison groups (depressed vs. not depressed) be at the same level for the adjusted covariates. For depressed mood and diabetes distress, group comparisons for HbA1c were performed using analysis of covariance at each time point to control for the potential confounding effect of age, gender, body mass index (BMI), education, duration of diabetes, initiated insulin type, and microvascular and macrovascular complications. For comparison of HbA1c between groups with and without a history of diagnosed depression, a longitudinal, likelihood-based repeated measures mixed model analysis was used, controlling for age, gender, BMI, education, duration of diabetes, initiated insulin type, and microvascular and macrovascular complications. Analyses were exploratory in that they were not planned as part of the analyses supporting the original publication for this study. However, the analyses and the hypotheses they address were planned and prespecified prior to their being conducted. Results for all analyses were considered statistically significant for p\0.05. SAS version 9.2 (Cary, NC, USA) was used for all analyses.
Compliance with Ethics
Within the TREAT study, all treatment decisions were made between the physician and patient, and care was provided at the discretion of the physician and according to local standards of medical care. All patients provided written informed consent according to local regulations. Most study participants (752; 76.3%) have completed the 24-month study. Reasons for discontinuations (n; %) included: lost to followup (70; 7.1%); physician decision (70; 7.1%); subject decision (63; 6.4%); death (22; 2.2%); missing (7; 0.7%); and sponsor decision (2; 0.2%). Using a comparative analysis stratified by country, the 752 study completers were not found to significantly differ from the 234 study dropouts on any of the studied baseline characteristics. There was, however, one baseline characteristic with a marginally significant difference between the completers and dropouts. There were a lower percentage of dropouts with a history of depression diagnosis at baseline compared to study completers.
(9.2% vs. 13.9%, p = 0.054).
Cross-Sectional Analysis at Baseline
HbA1c was significantly (adjusted and unadjusted, p B 0.001) higher in patients with a history of diagnosed depression than in patients without (10.77% vs. 9.36%). HbA1c was similar in patients with depressed mood compared to those without depressed mood (Table 1 ). HbA1c was significantly higher (unadjusted, p B 0.001) in patients with high diabetes distress compared to patients with low distress (9.91% vs. 9.39%). Differences were not statistically significant in the adjusted analysis (p = 0.701).
Longitudinal Analysis
The proportion of patients with depressed mood declined over time (from 49.9% to 37.0%, p\0.001; Fig. 1a ), while the proportion of patients with high diabetes distress did not decline significantly over time (from 29.9% to 26.7%, p = 0.098; Fig. 1b ).
Over the 24 months following insulin initiation, glycemic control (as measured by mean HbA1c) improved, regardless of the presence or absence of depression defined by each parameter as shown in Fig. 2 . Patients with a history of diagnosed depression had significantly higher HbA1c values during the first 6 months following insulin initiation (HbA1c values decreased over time from Fig. 2 a Mean HbA1c over 24 months by history of diagnosed depression at baseline. Presented results are from the unadjusted analysis. Results from the adjusted analysis showed a similar pattern as the unadjusted analysis. Group differences were, however, no longer statistically significant at 6 months and became significant in the opposite direction at 18 and 24 months. b Mean HbA1c over 24 months by depressed mood. Presented results are from the unadjusted analysis. Results from the adjusted analysis showed the same pattern as the unadjusted analysis. Group differences were, however, no longer statistically significant at 3 and 6 months. c Mean HbA1c over 24 months by diabetes distress. High diabetes distress is defined as a score C75th percentile on the DHP-18 Psychological Distress domain score at each assessment. Results are presented from the unadjusted analysis. Results from the adjusted analysis showed the same pattern as the unadjusted analysis. Group differences were, however, no longer statistically significant at baseline. DHP-18 Psychological Distress domain of the Diabetes Health Profile, HbA1c glycated hemoglobin. *Significant difference between the groups with vs. without the depression parameter at p B 0.05. **Significant difference between the groups with vs. without the depression parameter at p B 0.01. ***Significant difference between the groups with vs. without the depression parameter at p B 0.001. D = Difference between groups 10.77% to 8.22%) than those without a history of diagnosis (HbA1c values decreased from 9.36% to 7.74%) (unadjusted p\0.01; Fig. 2a ), but not at subsequent time points (12 months, p = 0.078; 18 months, p = 0.872; 24 months, p = 0.193). Over the 24 months, patients with depressed mood continued to have higher HbA1c (HbA1c values decreased from 9.62% to 7.79%) compared to patients without depressed mood (HbA1c values decreased from 9.48% to 7.45%) (unadjusted p B 0.01; Fig. 2b ). Higher HbA1c values were consistently observed in patients with high diabetes distress (HbA1c values decreased from 9.91% to 7.90%) compared to patient without high diabetes distress (HbA1c values decreased from 9.39% to 7.48%) throughout the study period (unadjusted p\0.001; Fig. 2c ). Results from the adjusted analysis showed similar patterns (results not shown). Table 2 presents the correlations between the three depression and distress parameters over the 24 months following insulin initiation. The three measures were positively and significantly correlated at baseline, although the magnitude of the associations was relatively low, with the higher correlation observed between depressed mood and diabetes distress (r = 0.396). Results from the adjusted analysis showed the same pattern as the unadjusted analysis. *Significant difference between the groups with vs. without the depression parameter at p B 0.05. **Significant difference between the groups with vs. without the depression parameter at p B 0.01. ***Significant difference between the groups with vs. without the depression parameter at p B 0.001. D = Difference between groups shows the longitudinal relationships between the depression parameters. In the first 12 months post-initiation of insulin therapy, patients with a history of diagnosed depression had significantly higher mean scores on the depressive mood item compared to patients without a history of diagnosed depression (Fig. 3a) . Similarly, Fig. 3b and c shows relationships between diabetes distress and history of diagnosed depression, and depressed mood by baseline diabetesrelated distress. In all cases, the presence of depression at baseline is associated with the presence of more symptoms over time. Results from the adjusted analysis showed essentially the same pattern (results not shown).
Correlations Between Depression and Distress Measures

Sensitivity Analyses
As study participants were enrolled from five European countries (Greece, Portugal, Romania, Sweden, and Turkey), we also assessed-as a sensitivity analysis-the potential impact of country on the current results by repeating the original analyses in two ways: we first reanalyzed the findings while stratifying by 
DISCUSSION
This exploratory, post hoc analysis found consistent and significant associations between poorer glycemic control and each of the three depression and distress parameters: history of depression diagnosis, depressed mood, and diabetes distress in T2DM patients who initiated insulin therapy. This analysis also demonstrated that patients with higher depression parameters or distress at baseline had significantly higher rates of microvascular complications. Poor glycemic control has indeed been associated with development of diabetic complications [45] , and these complications are probably a more direct cause of depressive mood in patients with higher
HbA1c than HbA1c alone. In addition, these results show that initiation of insulin therapy was associated with improved glycemic control, and the proportion of patients with preexisting depressed mood decreased significantly (by 13% overall from 49.9% to 37.0%) and resulted in numerically, but not statistically significant, reductions in the proportion of patients with preexisting high diabetes distress (from 29.9% to 26.7%, p = 0.098). Consistent with prior research, a substantial proportion of patients with T2DM in this cohort were experiencing depression or emotional distress, as measured by the three proxy measures of depression. History of depression diagnosis was present in 12.4% of the patients, a finding congruent with previous studies that estimated the prevalence of major depression in diabetes to be around 12% (ranging from 8% to 18%) [2, 46, 47] . Depressed mood was reported by 50% of patients and diabetes-related distress by 30%.
Although the positive associations between poorer glycemic control and depression parameters were observed at baseline for only two of the three depression parameters (history of depression diagnosis and diabetes distress), there was a higher rate of microvascular complications for all three parameters. While the mean HbA1c values improved for patients during the 24 months following insulin initiation, glycemic control was poorer for patients with, compared to without, the depressive parameters. A higher HbA1c at baseline is, however, associated with a higher HbA1c at endpoint after insulin treatment, although the decrease in HbA1c is higher [48, 49] . A higher HbA1c at baseline was also associated with higher HbA1c at endpoint in the TREAT study [44] . In this analysis, insulin regimens were similar between groups with or without depressive parameters, and thus a higher HbA1c at endpoint is not unexpected and probably more linked to the difficulty and need of more complex insulin regimens in patients with worse glycemic control at insulin initiation than to depressive parameters.
The consistent findings may be due, at least in part, to the positive and significant interrelationships between the depression parameters. Although the correlations were relatively small in magnitude, the correlation between diabetes distress and depressed mood was higher (r = 0.396). This is consistent with prior research [28] , which reported a correlation of r = 0.48 between depressed mood and diabetes distress. Therefore, current findings suggest that the different depression parameters may capture a different but interrelated condition that may require additional assessment and management to optimize glycemic control in patients with T2DM. 
CONCLUSIONS
Current findings of a decline in the proportion of patients with depressive mood from preinitiation to post-initiation of insulin therapy may suggest that once the barriers associated with insulin treatment have been addressed, depressed mood improves with better glycemic control. A better understanding of the relationship between glycemic control, diabetic complications, and specific affective parameters may help clinicians to focus more attention on screening for affective conditions and provide information that may lead to more timely treatment or referrals to both mental health and diabetes professionals. In addition to the potential beneficial impact on clinical practice and patients' outcomes, such information may also be useful for diabetes research, as it may help highlight the need to evaluate specific potential affective confounders when assessing glycemic control among patients with T2DM, in either cross-sectional or longitudinal manner. 
